Literature DB >> 9035061

Study design and statistical analysis of toxicokinetics: a report of JPMA investigation of case studies.

T Igarashi1, T Yabe, K Noda.   

Abstract

In 1994, the Japanese Pharmaceutical Manufacturers Association (JPMA) conducted a questionnaire survey on case studies of toxicokinetics which were recently conducted its member companies. The present paper summarizes study designs and results of data analysis of 102 cases of repeated oral dose toxicity studies with dogs, monkeys, rats or mice. The statistical analysis of toxicokinetic data introduced in this paper, e.g. log-transformation of concentration data, analysis of variance and regression analysis, may be useful in clarifying the comprehensive effects of test doses, duration of repeated dosing, and sex of test animal on the systemic exposure. Suggestions are made on how experimental design can aid the efficient conduct of toxicokinetic studies in the face of limits on the number of animals.

Entities:  

Mesh:

Year:  1996        PMID: 9035061     DOI: 10.2131/jts.21.5_497

Source DB:  PubMed          Journal:  J Toxicol Sci        ISSN: 0388-1350            Impact factor:   2.196


  5 in total

Review 1.  Is the use of sentient animals in basic research justifiable?

Authors:  Ray Greek; Jean Greek
Journal:  Philos Ethics Humanit Med       Date:  2010-09-08       Impact factor: 2.464

Review 2.  The Nuremberg Code subverts human health and safety by requiring animal modeling.

Authors:  Ray Greek; Annalea Pippus; Lawrence A Hansen
Journal:  BMC Med Ethics       Date:  2012-07-08       Impact factor: 2.652

Review 3.  Systematic reviews of animal models: methodology versus epistemology.

Authors:  Ray Greek; Andre Menache
Journal:  Int J Med Sci       Date:  2013-01-11       Impact factor: 3.738

4.  Food Effect on a Single High Dose of Carotegrast Methyl, an Oral Antagonist of α4-Integrin, in Healthy Male Subjects: A Randomised, Placebo-Controlled, Double-Blind Study.

Authors:  Hiroyuki Fukase; Toshifumi Kajioka; Ichiro Oikawa; Naoki Ikeda; Hidetoshi Furuie
Journal:  Clin Drug Investig       Date:  2020-03       Impact factor: 2.859

5.  AJM300, a novel oral antagonist of α4-integrin, sustains an increase in circulating lymphocytes: A randomised controlled trial in healthy male subjects.

Authors:  Hiroyuki Fukase; Toshifumi Kajioka; Ichiro Oikawa; Naoki Ikeda; Hidetoshi Furuie
Journal:  Br J Clin Pharmacol       Date:  2020-01-28       Impact factor: 4.335

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.